EDGAR Filing Documents for 0000217028-05-000005

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000217028-05-000005

Filing Date

2005-09-09

Accepted

2005-09-09 10:55:52

Documents

Period of Report

2005-09-07

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	4
1	PRIMARY DOCUMENT	primary_doc.xml	4	4402
	Complete submission text file	0000217028-05-000005.txt		7115

Mailing Address

Business Address 500 ARCOLA RD P O BOX 1200 M/S 5B14 COLLEGEVILLE PA 19426-0107 6104548000

AVENTIS INC (Reporting) CIK: 0000217028 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21291 | Film No.: 051076725
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701

Business Address 301 CONGRESS AVE SUITE 1850 AUSTIN TX 78701 5127089310

INTROGEN THERAPEUTICS INC (Issuer) CIK: 0001018710 (see all company filings)

IRS No.: 742704230 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3711 KENNETH PIKE GREENVILLE DE 19807

Business Address 3711 KENNETH PIKE GREENVILLE DE 19807 3027777222

AVENTIS HOLDINGS INC (Reporting) CIK: 0001267075 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-21291 | Film No.: 051076724